M. Glezerman et al., TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 ARE DIFFERENTLY EXPRESSED BY FRESH HUMAN CANCEROUS OVARIAN TISSUE AND PRIMARY-CELL LINES, European cytokine network, 9(2), 1998, pp. 171-179
The expression levels of tumor necrosis factor-alpha (TNF-alpha) and i
nterleukin-6 (IL-6) were evaluated in normal and cancerous ovarian tis
sue and primary cell lines (PCL), Seven normal and 10 cancerous, forma
lin-fixed ovarian samples were examined for TNF-alpha and IL-6 express
ion by immunohistochemical staining using polyclonal rabbit anti-human
TNF-alpha and IL-6 antibodies. Fresh normal and cancerous specimens w
ere also examined for TNF-alpha and IL-6 secretion by bioassay and imm
unoassay prior to and following in vitro stimulation with lipopolysacc
haride (LPS). The levels of IL-6 and TNF-alpha were higher in cancerou
s tissues than in normal specimens. In vitro stimulation of normal and
cancerous ovarian tissues and PCL revealed their capacity to secrete
IL-6. Cancerous tissue and PCL secreted higher levels than normal tiss
ue and PCL. Stimulation of both groups with LPS increased their capaci
ty to secrete IL-6. Optimal secretion of IL-6 by the cancerous tissue
was observed after 72 hours with or without LPS (10 mu g/ml), Normal t
issue secreted maximal levels of IL-6 after 96 hours with or without L
PS. PCL from normal ovarian tissue secreted IL-6 constitutively and op
timal expression was detected after 96 hours. Carcinoma PCL from cance
rous ovarian tissue demonstrated optimal secretion of IL-6 after 24 ho
urs. Stimulation of both types of cells with LPS, IL-1 or TNF-alpha, i
ncreased their capacity to secrete IL-6, TNF-alpha activity was detect
ed in vitro only in supernatants of ovarian cancerous tissue and only
after LPS stimulation; optimal levels were detected after 48 hours and
1 mu g/ml LPS. Our results indicate that IL-6 and TNF-alpha are expre
ssed in cancerous ovarian tissue at a higher level than in normal ovar
ian tissues. Carcinoma cells of ovarian tissues are the main cellular
source of these cytokines. The conditions controlling the secretion of
these cytokines? under irt vitro conditions, are different in cancero
us and normal ovarian tissues.